1. Home
  2. News

News

infographic of 11 countries in FORCE-initiative

Joining a Europe-wide alliance to scale-up research on rare and hard-to-treat cancers

The Anticancer Fund is now part of FORCE, a major European initiative supporting research on rare and hard-to-treat cancers. Alongside 13 non-profit partners from 11 countries, we’re working to bring better, evidence-based treatments to patients who urgently need them.

Milestone 1000 patients in trials Anticancer Fund

More than 1.000 patients participating in Anticancer Fund clinical trials

On International Clinical Trials Day, we’ve reached a milestone: more than 1.000 patients are participating in our 7 ongoing clinical trials across 31 countries. These numbers represent more than data — they represent progress, and lives. Discover how smart research is driving change.

Brain tumour in children - U-R-Immune Glioma trial by Anticancer Fund

New clinical trial targets aggressive brain tumours in children and young adults

We started a global trial, U-R-Immune Glioma, investigating whether Immune therapy can offer an alternative treatment for children and young adults with brain tumours. In collaboration with SickKids and CHEO in Canada.

Patient and health systems opportunities

Bertolini, F., Sukhatme, V.P., & Bouche, G. (2015). Drug repurposing in oncology—patient and health systems opportunities. Nature Reviews Clinical Oncology, 12(12):732-42. doi:10.1038/nrclinonc.2015.169

ReDO: nitroglycerin as an anti-cancer agent

Sukhatme, V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015). Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent. Ecancermedicalscience, 9, 568. doi:10.3332/ecancer.2015.568

Therapeutic effect of Cryoablation and Meriva in Breast Cancer

Chandra, D., Jahangir, A., Cornelis, F., Rombauts, K., Meheus, L., Jorcyk, C. L., & Gravekamp, C. (2015). Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer. Oncoimmunology, 5(1), e1049802. doi:10.1080/2162402X.2015.1049802